Company intelligence / Profile preview

Nephrolytics

Ownership: Private
Development stage: Commercial

Overview

Nephrolytics has launched its flagship platform Saya™, an AI-driven clinical agent that automates SOAP note creation, streamlines workflows, and provides real-time decision support by integrating data from EMRs, labs, hospitals, and HIEs. The company reports a 40% reduction in documentation time and a 33% increase in coding accuracy for users. Saya™ is now fully deployed at Idaho Kidney Institute with national rollout underway.

Therapeutic areas: Nephrology
Modalities: Digital health/AI-driven clinical decision support (not therapeutics such as small molecules or mAbs)
Industry: Digital Health Medical Devices

Partnerships

Idaho Kidney Institute

Beyond the preview

Go deeper on Nephrolytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nephrolytics.

Explore the full profile